I loathe Fox but you should be pissed about this. CytoDyn’s Pro-140 aka Leronlimab is a monoclonal antibody that is safe and seems to be an effective treatment for a wide range of diseases, including cancer. But past mismanagement and BP suppressed it for years. This will change in 2026.
Charlie Sheen claims experimental HIV drug was kept off market because 'it's a threat' to industry
Charlie Sheen reveals an experimental HIV drug that "never made it to market" and discusses his sobriety journey since 2017 in a candid podcast interview.
www.foxnews.com
December 10, 2025 at 11:02 PM
I loathe Fox but you should be pissed about this. CytoDyn’s Pro-140 aka Leronlimab is a monoclonal antibody that is safe and seems to be an effective treatment for a wide range of diseases, including cancer. But past mismanagement and BP suppressed it for years. This will change in 2026.
Cure is already here: Leronlimab + ICI. FDA just needs to catch up.
November 17, 2025 at 6:07 AM
Cure is already here: Leronlimab + ICI. FDA just needs to catch up.
Leronlimab directly binds the extracellular domains of CCR5, modulates downstream signaling and potentially can slow, reverse, or prevent fibrosis. In this proof‐of‐concept study, our Hansen Lab with contributors, demonstrated that leronlimab has a favorable safety profile and was well tolerated.
October 21, 2025 at 4:22 PM
Leronlimab directly binds the extracellular domains of CCR5, modulates downstream signaling and potentially can slow, reverse, or prevent fibrosis. In this proof‐of‐concept study, our Hansen Lab with contributors, demonstrated that leronlimab has a favorable safety profile and was well tolerated.
Quick.....700mg of Leronlimab, stat!
September 22, 2025 at 12:05 AM
Quick.....700mg of Leronlimab, stat!
$CYDY is exploring Leronlimab + pembrolizumab (Keytruda) in preclinical mTNBC models. Combo could enhance TME modulation + checkpoint efficacy. Still preclinical, but a step toward immuno-oncology relevance. Keep an eye on IND movement. #oncology Not financial advice do your own due diligence.
August 6, 2025 at 5:55 AM
$CYDY is exploring Leronlimab + pembrolizumab (Keytruda) in preclinical mTNBC models. Combo could enhance TME modulation + checkpoint efficacy. Still preclinical, but a step toward immuno-oncology relevance. Keep an eye on IND movement. #oncology Not financial advice do your own due diligence.
CytoDyn’s now testing Leronlimab with Keytruda in mTNBC. Preclinical stage — but this could be a real pivot into immuno-oncology if the data holds. #biotech #Leronlimab
Not financial advice do your own due diligence
Not financial advice do your own due diligence
August 6, 2025 at 5:54 AM
CytoDyn’s now testing Leronlimab with Keytruda in mTNBC. Preclinical stage — but this could be a real pivot into immuno-oncology if the data holds. #biotech #Leronlimab
Not financial advice do your own due diligence
Not financial advice do your own due diligence
Science is amazing,This is not financial advice do your own DD.
CytoDyn’s testing Leronlimab + Keytruda in a tough type of breast cancer (mTNBC). It’s early (preclinical), but the combo makes sense. Could be big if it moves to trials and shows results. One to watch.
CytoDyn’s testing Leronlimab + Keytruda in a tough type of breast cancer (mTNBC). It’s early (preclinical), but the combo makes sense. Could be big if it moves to trials and shows results. One to watch.
August 6, 2025 at 5:52 AM
Science is amazing,This is not financial advice do your own DD.
CytoDyn’s testing Leronlimab + Keytruda in a tough type of breast cancer (mTNBC). It’s early (preclinical), but the combo makes sense. Could be big if it moves to trials and shows results. One to watch.
CytoDyn’s testing Leronlimab + Keytruda in a tough type of breast cancer (mTNBC). It’s early (preclinical), but the combo makes sense. Could be big if it moves to trials and shows results. One to watch.
Ditto for Leronlimab, a monoclonal antibody which seems to turn cold tumors hot, enabling checkpoint inhibitors to destroy them.
The world is going to shit but there are some exciting medical advancements happening right now.
The world is going to shit but there are some exciting medical advancements happening right now.
June 22, 2025 at 8:30 PM
Ditto for Leronlimab, a monoclonal antibody which seems to turn cold tumors hot, enabling checkpoint inhibitors to destroy them.
The world is going to shit but there are some exciting medical advancements happening right now.
The world is going to shit but there are some exciting medical advancements happening right now.
Leronlimab a product of Cytodyn has better results , why hasn’t it been approved? Not only is there evidence to suggest its works better patients with cancer have also taken it and the results are staggering. WHO IS HOLDING THIS FROM AMERICANS? BP or FDA ???
June 19, 2025 at 7:44 PM
Leronlimab a product of Cytodyn has better results , why hasn’t it been approved? Not only is there evidence to suggest its works better patients with cancer have also taken it and the results are staggering. WHO IS HOLDING THIS FROM AMERICANS? BP or FDA ???
Cytodyn has a far better therapeutic - Leronlimab
But for some reason the FDA has been sitting on their hands
But for some reason the FDA has been sitting on their hands
May 31, 2025 at 1:13 PM
Cytodyn has a far better therapeutic - Leronlimab
But for some reason the FDA has been sitting on their hands
But for some reason the FDA has been sitting on their hands
We have potential cures but the FDA approval process is antiquated and inefficient.
A company at the ESMO conference last week revealed data on the drug Leronlimab. It was given to women who failed 4 treatments for breast cancer. 4 of them are still alive 4 yrs later with no cancer in their body.
A company at the ESMO conference last week revealed data on the drug Leronlimab. It was given to women who failed 4 treatments for breast cancer. 4 of them are still alive 4 yrs later with no cancer in their body.
May 18, 2025 at 10:22 PM
We have potential cures but the FDA approval process is antiquated and inefficient.
A company at the ESMO conference last week revealed data on the drug Leronlimab. It was given to women who failed 4 treatments for breast cancer. 4 of them are still alive 4 yrs later with no cancer in their body.
A company at the ESMO conference last week revealed data on the drug Leronlimab. It was given to women who failed 4 treatments for breast cancer. 4 of them are still alive 4 yrs later with no cancer in their body.
Do you know anyone with metastatic triple negative breast cancer? Hope is on the horizon with Cytodyn’s Leronlimab.
#mtnbc #cancer #breastcancer
$CYDY. More news coming soon
www.cytodyn.com/newsroom/pre...
#mtnbc #cancer #breastcancer
$CYDY. More news coming soon
www.cytodyn.com/newsroom/pre...
CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors
CytoDyn is a publicly traded clinical stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targe...
www.cytodyn.com
May 13, 2025 at 9:10 PM
Do you know anyone with metastatic triple negative breast cancer? Hope is on the horizon with Cytodyn’s Leronlimab.
#mtnbc #cancer #breastcancer
$CYDY. More news coming soon
www.cytodyn.com/newsroom/pre...
#mtnbc #cancer #breastcancer
$CYDY. More news coming soon
www.cytodyn.com/newsroom/pre...
Our Sacha and Hansen lab teams with contributors, have been investigating Leronlimab as a treatment option for people living with multidrug-resistant HIV-1. Great work by all!
Read the full article here: pubmed.ncbi.nlm.nih.gov/39972543/
Read the full article here: pubmed.ncbi.nlm.nih.gov/39972543/
May 13, 2025 at 3:58 PM
Our Sacha and Hansen lab teams with contributors, have been investigating Leronlimab as a treatment option for people living with multidrug-resistant HIV-1. Great work by all!
Read the full article here: pubmed.ncbi.nlm.nih.gov/39972543/
Read the full article here: pubmed.ncbi.nlm.nih.gov/39972543/
Encouraging survival outcomes among a group of patients with metastatic triple-negative breast cancer (“mTNBC”) treated with leronlimab.
www.cytodyn.com/newsroom/pre...
www.cytodyn.com/newsroom/pre...
CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab
CytoDyn is a publicly traded clinical stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targe...
www.cytodyn.com
May 10, 2025 at 1:25 PM
Encouraging survival outcomes among a group of patients with metastatic triple-negative breast cancer (“mTNBC”) treated with leronlimab.
www.cytodyn.com/newsroom/pre...
www.cytodyn.com/newsroom/pre...
LERONLIMAB is the answer Cydy
May 9, 2025 at 4:55 PM
LERONLIMAB is the answer Cydy
He received CCR5 antagonist monoclonal antibody Leronlimab from Cytodyn Corp.
April 4, 2025 at 1:48 AM
He received CCR5 antagonist monoclonal antibody Leronlimab from Cytodyn Corp.
Congratulations to our Sacha affiliate lab team, Hansen lab team, and their contributors! They recently published a new paper on Leronlimab Treatment for Multidrug-Resistant HIV-1.
Read more at pubmed.ncbi.nlm.nih.gov/39972543/
Read more at pubmed.ncbi.nlm.nih.gov/39972543/
February 25, 2025 at 7:28 PM
Congratulations to our Sacha affiliate lab team, Hansen lab team, and their contributors! They recently published a new paper on Leronlimab Treatment for Multidrug-Resistant HIV-1.
Read more at pubmed.ncbi.nlm.nih.gov/39972543/
Read more at pubmed.ncbi.nlm.nih.gov/39972543/
$CYDY. Now at $.02989, more than double when I first alerted. We are looking at a likely CURE for HIV. First, Bill and Melinda Gates foundation hires our SVP and yesterday donates almost $1mill to our top #leronlimab researcher. Miracle drug is on the way.
February 23, 2025 at 3:50 PM
$CYDY. Now at $.02989, more than double when I first alerted. We are looking at a likely CURE for HIV. First, Bill and Melinda Gates foundation hires our SVP and yesterday donates almost $1mill to our top #leronlimab researcher. Miracle drug is on the way.
$CYDY. Now at $.02989, more than double when I first alerted. We are looking at a likely CURE for HIV. First, Bill and Melinda Gates foundation hires our SVP and yesterday donates almost $1mill to our top #leronlimab researcher. Miracle drug is on the way.
February 23, 2025 at 3:48 PM
$CYDY. Now at $.02989, more than double when I first alerted. We are looking at a likely CURE for HIV. First, Bill and Melinda Gates foundation hires our SVP and yesterday donates almost $1mill to our top #leronlimab researcher. Miracle drug is on the way.
You didn't support Leronlimab
I'll pass on your guidance
I'll pass on your guidance
January 20, 2025 at 6:01 PM
You didn't support Leronlimab
I'll pass on your guidance
I'll pass on your guidance
Until they fund a trial for Leronlimab, I will remain unimpressed
www.uclahealth.org/news/release...
www.uclahealth.org/news/release...
Some cases of long COVID-19 may be caused by an abnormally suppressed immune system, UCLA-led research suggests
A UCLA-led team of researchers studying the effect of the monoclonal antibody Leronlimab on long COVID-19 may have found a surprising clue to the baffling syndrome, one that contradicts their initial ...
www.uclahealth.org
December 21, 2024 at 6:44 PM
Until they fund a trial for Leronlimab, I will remain unimpressed
www.uclahealth.org/news/release...
www.uclahealth.org/news/release...
Leronlimab from cytodyn
December 17, 2024 at 9:55 PM
Leronlimab from cytodyn
It's called Leronlimab/Livimmune
Dissed by the FDA/NIH. Best CCR5 antagonist on the planet
It's ability to fight cancer, HIV buried in bureaucracy
This 2020 article scrubbed from the internet
Dissed by the FDA/NIH. Best CCR5 antagonist on the planet
It's ability to fight cancer, HIV buried in bureaucracy
This 2020 article scrubbed from the internet
December 14, 2024 at 6:20 PM
It's called Leronlimab/Livimmune
Dissed by the FDA/NIH. Best CCR5 antagonist on the planet
It's ability to fight cancer, HIV buried in bureaucracy
This 2020 article scrubbed from the internet
Dissed by the FDA/NIH. Best CCR5 antagonist on the planet
It's ability to fight cancer, HIV buried in bureaucracy
This 2020 article scrubbed from the internet
💊The #DepartmentofJustice⚖️announced its latest clinical trial #fraud enforcement success. Two executives have been convicted of lying to investors about the promise of a drug called leronlimab that their companies were promoting to treat HIV and #COVID-19. 🩺 constantinecannon.com/whistleblowe...
Another Clinical Trial Fraud Success for Government Enforcement: Bring on the Clinical Trial Fraud Whistleblowers - Constantine Cannon
The DOJ announced the latest clinical trial fraud enforcement success with the conviction of two chief executives for lying to investors about the supposed promise of a drug called Leronlimab their co...
constantinecannon.com
December 13, 2024 at 1:05 PM
💊The #DepartmentofJustice⚖️announced its latest clinical trial #fraud enforcement success. Two executives have been convicted of lying to investors about the promise of a drug called leronlimab that their companies were promoting to treat HIV and #COVID-19. 🩺 constantinecannon.com/whistleblowe...
Keep an eye on Leronlimab trials too. Glioblastomas, CRC, Alzheimer’s, HIV/inflammation, etc. Incredible potential to become a platform drug.
December 12, 2024 at 4:58 PM
Keep an eye on Leronlimab trials too. Glioblastomas, CRC, Alzheimer’s, HIV/inflammation, etc. Incredible potential to become a platform drug.